Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
July 22 2021 - 6:05AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the Month of July 2021
Commission File Number: 001-38746
Taiwan Liposome Company, Ltd.
(Translation of registrant’s name into English)
Taiwan Liposome Company, Ltd.
11F-1, No. 3 Yuanqu Street
Nangang District,
Taipei City, Taiwan 11503
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Filing with the Taipei Exchange dated July 22, 2021
On July 22, 2021, Taiwan Liposome Company, Ltd. made a supplement filing with the Taipei Exchange’s Market Observation Post System for the privatization transaction previously mentioned in the Form 6-K dated July 6, 2021.
A copy of the Taipei Exchange’s Market Observation Post System filing is attached hereto as Exhibit 99.1.
Exhibits
|
Exhibit
Number
|
|
Exhibit Description
|
|
99.1
|
|
Filing with the Taipei Exchange’s Market Observation Post System, dated July 22, 2021.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
TAIWAN LIPOSOME COMPANY, LTD.
|
|
|
|
|
|
Date: July 22, 2021
|
|
By:
|
|
/s/ George Yeh
|
|
|
|
Name:
|
|
George Yeh
|
|
|
|
Title:
|
|
President
|
Taiwan Liposome (NASDAQ:TLC)
Historical Stock Chart
From Oct 2024 to Nov 2024
Taiwan Liposome (NASDAQ:TLC)
Historical Stock Chart
From Nov 2023 to Nov 2024
